Skip to content
Inciteful Med

Building Your Care Team: Specialists and Preparation

Last updated:

Managing Autosomal Dominant Optic Atrophy (ADOA) requires a specialized care team led by a neuro-ophthalmologist. Patients should also work with genetic counselors and low vision specialists, and come prepared to appointments with past OCT scans and genetic test results.

Key Takeaways

  • • A neuro-ophthalmologist is the most essential doctor for managing Autosomal Dominant Optic Atrophy (ADOA).
  • • Your core care team should also include a genetic counselor to discuss family planning and a low vision specialist for visual aids.
  • • If you have ADOA-Plus, your team will expand to include an audiologist for hearing tests and a neurologist for coordination or muscle issues.
  • • Bring your genetic test results, past OCT scans, visual field reports, and family medical history to your first specialist appointment.
  • • Always ask your specialist about their experience with ADOA and OPA1 mutations to ensure you receive expert care.

When you are diagnosed with a rare condition like Autosomal Dominant Optic Atrophy (ADOA), you shouldn’t just be a patient—you should be the leader of your own care team. Because ADOA can be complex, building a specialized network of experts ensures that every aspect of your health—from your vision to your genetics—is monitored correctly.

Your ADOA Care Team

A “comprehensive” care team involves several specialists who work together to manage the condition.

  • The Quarterback: Neuro-ophthalmologist: This is the most essential member of your team. Unlike a general eye doctor, a neuro-ophthalmologist specializes in the connection between the eyes and the brain [1][2]. They will use advanced tools like OCT to track the health of your retinal ganglion cells [3][4].
  • The Genetic Expert: Genetic Counselor: They help you interpret your OPA1 test results, explain the risks to family members, and assist with family planning [5][6].
  • The Functional Expert: Low Vision Specialist: These specialists focus on maximizing the vision you do have. They provide tools like high-powered magnifiers and digital aids to help with school, work, and daily life [1].
  • The “Plus” Specialists: If ADOA-Plus is suspected, you may also need:
    • Audiologist: To perform regular hearing tests (audiograms) to monitor for auditory neuropathy [7][8].
    • Neurologist: To evaluate for any issues with coordination (ataxia) or muscle strength (myopathy) [9][7].

Preparing for Your First Appointment

Your first visit with a specialist is the most important one. To make the most of it, you should bring the following documentation:

  1. Genetic Test Results: A full copy of your molecular report (especially details about the OPA1 mutation) [1][10].
  2. Historical OCT Scans: If you have had OCT scans in the past, bring the raw data or digital images. Your specialist needs these to see if your nerve thickness has changed over time [3][11].
  3. Visual Field Results: Any previous “Humphrey” or visual field test reports [12][3].
  4. Family Medical History: A simple “family tree” noting anyone with vision loss, “lazy eye,” or early-onset hearing loss [3][1].

Advocating for Expertise

Because ADOA is rare, not every eye doctor will be an expert. You have the right to “vet” your specialist to ensure they have the experience you need. Consider asking:

  • “How many patients with ADOA or OPA1 mutations do you currently treat?” (Experience with this specific condition is key).
  • “Are you familiar with the specific OCT patterns (like nasal inner macula thinning) associated with ADOA?” (This ensures they know what markers to look for) [11].
  • “Are you familiar with emerging research and current clinical trials for ADOA?” (This gauges their involvement in the broader ADOA research community without demanding they be a specific trial site) [13][14].

By building a team that understands the nuances of ADOA, you move from a place of uncertainty to a place of proactive management [15].

Frequently Asked Questions

What type of doctor is best for treating ADOA?
A neuro-ophthalmologist is the most essential specialist for managing Autosomal Dominant Optic Atrophy. Unlike a general eye doctor, they specialize in the connection between the eyes and the brain and use advanced tools like OCT scans to track your optic nerve health.
What documents should I bring to my first ADOA appointment?
You should bring your complete molecular genetic test results, especially details about any OPA1 mutations. It is also crucial to bring historical OCT scans, visual field test results, and a family tree noting any relatives with vision or hearing loss.
Do I need other specialists besides an eye doctor for ADOA?
Yes, a comprehensive care team typically includes a genetic counselor to interpret test results and a low vision specialist to provide practical visual aids. If you have ADOA-Plus, you may also need an audiologist to monitor your hearing and a neurologist for muscle or coordination issues.
How can I tell if my doctor has enough experience with ADOA?
You can advocate for yourself by directly asking the doctor how many patients with ADOA or OPA1 mutations they currently manage. You can also ask if they are familiar with specific tracking methods for ADOA, such as looking for nasal inner macula thinning on OCT scans.
Why might I need an audiologist or neurologist if I have an eye condition?
Some people with this genetic mutation develop a subtype called ADOA-Plus, which affects more than just vision. An audiologist can monitor for hearing loss or auditory neuropathy, while a neurologist can check for balance issues, coordination problems, and muscle weakness.

Questions for Your Doctor

  • • How many patients with ADOA or OPA1-related optic atrophy do you currently manage in your practice?
  • • Are you familiar with the specific OCT patterns (like nasal inner macula thinning) associated with ADOA, and how do you use that to monitor progression?
  • • Are you familiar with emerging research and current clinical trials for ADOA?
  • • Can you help coordinate my care with a genetic counselor to discuss family planning and relative screening?
  • • Based on my (or my child’s) mutation, should we be proactively screening for 'ADOA-plus' symptoms with an audiologist or neurologist?

Questions for You

  • • Do you have a clear family tree that notes any relatives with 'lazy eye,' unexplained vision loss, or hearing issues?
  • • Have you noticed any balance issues or muscle weakness that you previously thought were unrelated to your vision?
  • • Are you prepared to provide digital or physical copies of your past OCT scans to ensure the specialist can track changes over time?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    [Hereditary Optic Neuropathies].

    Rüther K

    Klinische Monatsblatter fur Augenheilkunde 2018; (235(6)):747-763 doi:10.1055/a-0583-6290.

    PMID: 29490390
  2. 2

    [Differential diagnosis of juvenile normal pressure glaucoma].

    Geidel K, Wiedemann P, Unterlauft JD

    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2017; (114(9)):828-831 doi:10.1007/s00347-016-0407-5.

    PMID: 27921132
  3. 3

    Clinical and Structural Parameters in Autosomal Dominant Optic Atrophy Patients: A Cross-Sectional Study Using Optical Coherence Tomography.

    Camós-Carreras A, Figueras-Roca M, Albà-Arbalat S, et al.

    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2024; (45(3)):273-277 doi:10.1097/WNO.0000000000002294.

    PMID: 39805076
  4. 4

    Comparison of Lamina Cribrosa Morphology in Normal Tension Glaucoma and Autosomal-Dominant Optic Atrophy.

    Kim GN, Kim JA, Kim MJ, et al.

    Investigative ophthalmology & visual science 2020; (61(5)):9 doi:10.1167/iovs.61.5.9.

    PMID: 32392317
  5. 5

    SARM1 loss protects retinal ganglion cells in a mouse model of autosomal dominant optic atrophy.

    Ding C, Ndiaye PS, Campbell SR, et al.

    The Journal of clinical investigation 2025; (135(12)).

    PMID: 40344041
  6. 6

    Genomics combined with a protein informatics platform to assess a novel pathogenic variant c.1024 A>G (p.K342E) in OPA1 in a patient with autosomal dominant optic atrophy.

    Ahuja AS, Selvam P, Vadlamudi C, et al.

    Ophthalmic genetics 2020; (41(6)):563-569 doi:10.1080/13816810.2020.1814344.

    PMID: 32940104
  7. 7

    A novel OPA1 mutation causing variable age of onset autosomal dominant optic atrophy plus in an Australian family.

    Ahmad KE, Davis RL, Sue CM

    Journal of neurology 2015; (262(10)):2323-8 doi:10.1007/s00415-015-7849-6.

    PMID: 26194196
  8. 8

    Autosomal dominant optic atrophy with OPA1 gene mutations accompanied by auditory neuropathy and other systemic complications in a Japanese cohort.

    Maeda-Katahira A, Nakamura N, Hayashi T, et al.

    Molecular vision 2019; (25()):559-573.

    PMID: 31673222
  9. 9

    Meta-analysis of genotype-phenotype analysis of OPA1 mutations in autosomal dominant optic atrophy.

    Ham M, Han J, Osann K, et al.

    Mitochondrion 2019; (46()):262-269 doi:10.1016/j.mito.2018.07.006.

    PMID: 30165240
  10. 10

    Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies.

    Lopez Sanchez MI, Crowston JG, Mackey DA, Trounce IA

    Pharmacology & therapeutics 2016; (165()):132-52.

    PMID: 27288727
  11. 11

    Thickness mapping of individual retinal layers and sectors by Spectralis SD-OCT in Autosomal Dominant Optic Atrophy.

    Corajevic N, Larsen M, Rönnbäck C

    Acta ophthalmologica 2018; (96(3)):251-256 doi:10.1111/aos.13588.

    PMID: 29091347
  12. 12

    Short Wavelength Automated Perimetry, Standard Automated Perimetry, and Optical Coherence Tomography in Dominant Optic Atrophy.

    Lombardo M, Cusumano A, Mancino R, et al.

    Journal of clinical medicine 2024; (13(7)) doi:10.3390/jcm13071971.

    PMID: 38610740
  13. 13

    OPA1: 516 unique variants and 831 patients registered in an updated centralized Variome database.

    Le Roux B, Lenaers G, Zanlonghi X, et al.

    Orphanet journal of rare diseases 2019; (14(1)):214 doi:10.1186/s13023-019-1187-1.

    PMID: 31500643
  14. 14

    Antisense Oligonucleotide STK-002 Increases OPA1 in Retina and Improves Mitochondrial Function in Autosomal Dominant Optic Atrophy Cells.

    Venkatesh A, McKenty T, Ali S, et al.

    Nucleic acid therapeutics 2024; (34(5)):221-233 doi:10.1089/nat.2024.0022.

    PMID: 39264859
  15. 15

    [Chinese expert consensus on the clinical diagnosis and treatment of autosomal dominant optic atrophy (2024)].

    ,

    [Zhonghua yan ke za zhi] Chinese journal of ophthalmology 2024; (60(3)):226-233 doi:10.3760/cma.j.cn112142-20231225-00308.

    PMID: 38462370

This page provides educational information about building a care team for ADOA. Always consult your neuro-ophthalmologist or specialized medical provider for personalized health advice and treatment.

Stay up to date

Get notified when new research about Autosomal dominant optic atrophy, classic form is published.

No spam. Unsubscribe anytime.